CNA Financial’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,516
| Closed | -$228K | – | 165 |
|
|
2022
Q3 | $228K | Sell |
10,516
-1,170
| -10% | -$25.4K | 0.09% | 158 |
|
|
2022
Q2 | $328K | Buy |
11,686
+3,510
| +43% | +$98.5K | 0.11% | 155 |
|
|
2022
Q1 | $377K | Buy |
8,176
+220
| +3% | +$10.1K | 0.12% | 164 |
|
|
2021
Q4 | $669K | Sell |
7,956
-1,410
| -15% | -$119K | 0.17% | 137 |
|
|
2021
Q3 | $624K | Buy |
9,366
+300
| +3% | +$20K | 0.17% | 150 |
|
|
2021
Q2 | $482K | Sell |
9,066
-2,380
| -21% | -$127K | 0.14% | 166 |
|
|
2021
Q1 | $497K | Buy |
11,446
+2,680
| +31% | +$116K | 0.15% | 159 |
|
|
2020
Q4 | $455K | Buy |
8,766
+380
| +5% | +$19.7K | 0.14% | 168 |
|
|
2020
Q3 | $274K | Buy |
8,386
+2,960
| +55% | +$96.7K | 0.1% | 173 |
|
|
2020
Q2 | $261K | Buy |
+5,426
| New | +$261K | 0.1% | 166 |
|